Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters











Publication year range
1.
Thromb Res ; 133(3): 412-7, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24388574

ABSTRACT

UNLABELLED: PMM2-CDG, the most frequent congenital disorder of N-glycosylation, is an autosomal recessive disease with a multisystem presentation. PMM2-CDG patients show an increased risk for thrombosis, which might be in part due to spontaneous platelet aggregations as previously described. A potential hypoglycosylation of platelet proteins in these patients might explain this increased reactivity, as removal of sialic acid from platelets, particularly of GPIbα, leads to enhance platelet aggregation and clearance from the circulation. This study is the first one that has evaluated the glycosylation status of platelet proteins in 6 PMM2-CDG patients using different approaches including immunoblot, RCA120 lectin binding to platelets and expression of different membrane platelet N-glycoproteins by flow cytometry, as well as by platelet N-glycoproteome analysis. RCA120 lectin binding to the platelet membrane of PMM2-CDG patients showed evidence for decreased sialic acid content. However, immunoblot and flow cytometric analysis of different platelet N-glycoproteins, together with the more sensitive 2D-DIGE analysis, suggest that platelet N-glycoproteins, including GPIbα, seem to be neither quantitatively nor qualitatively significantly affected. The increased binding of RCA120 lectin could be explained by the abnormal glycosylation of hepatic proteins being attached to the platelets. CONCLUSIONS: This is the first study that has evaluated the platelet N-glycoproteome. Our findings suggest that platelet proteins are not significantly affected in PMM2-CDG patients. Further studies are still warranted to unravel the mechanism(s) that increase(s) the risk of thrombosis in these patients.


Subject(s)
Congenital Disorders of Glycosylation/blood , Platelet Membrane Glycoproteins/analysis , Case-Control Studies , Glycosylation , Humans , Platelet Membrane Glycoproteins/metabolism , Proteomics
2.
Curr Med Chem ; 19(27): 4662-70, 2012.
Article in English | MEDLINE | ID: mdl-22830337

ABSTRACT

Blood platelets play a fundamental role in primary haemostasis and wound repair, but are also involved in several thrombotic and bleeding disorders for which the underlying mechanisms are still largely unknown. Elucidating platelet biology would help in finding novel disease biomarkers and drug targets in complex and/or genetically unknown platelet-related disorders. Proteomics, which allows studying thousands of gene products at once, represents an efficient tool to quali-quantitatively analyze and compare the platelet protein patterns of different samples (i.e. control/patient, treated/untreated, drug sensitive/resistant), to investigate post-translation modifications, protein-protein interactions and the underlying molecular pathways. This review gives an overview of the applications of proteomic strategies to study platelet biology and function, as well as to unravel differences in protein expression according to specific platelet conditions (i.e. basic versus activated), compartments (i.e. membrane or granules) and fractions (i.e. phosphoproteins and glycoproteins). The use of innovative powerful proteomic technologies can lead to the identification of proteins whose expression is altered in pathological conditions, allowing the identification of candidate biomarkers for: i) understanding the molecular defects underlying platelet disorders, ii) obtaining novel insights in more complex diseases that involve platelets, iii) unraveling the drug mode of action or identifying the mechanisms of drug resistance and iv) detecting novel therapeutic antiplatelet targets based on fundamental platelet research studies. Several studies on how proteomics proved to be useful in our understanding of platelet function and its diseases are discussed. Eventually, this could result in the discovery of novel drug targets for antiplatelet therapy.


Subject(s)
Blood Platelet Disorders/metabolism , Blood Platelets/metabolism , Platelet Aggregation Inhibitors/therapeutic use , Proteomics , Biomarkers/metabolism , Blood Platelet Disorders/drug therapy , Blood Platelet Disorders/pathology , Humans , Mass Spectrometry , Platelet Aggregation Inhibitors/chemistry , Proteome/metabolism
3.
J Thromb Haemost ; 8(7): 1594-603, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20403096

ABSTRACT

SUMMARY BACKGROUND: Regulator of G-protein signaling (RGS) 2 negatively regulates Gs signaling by inhibiting the activation of adenylyl cyclase (AC). RGS2 mRNA contains four translation initiation sites, leading to four isoforms with different abilities to inhibit AC activity; the largest isoform is the most pronounced inhibitor. A role for RGS2 in platelets is not known. OBJECTIVE: To describe a heterozygous RGS2 mutation (G23D) in three related patients, leading to Gs hypofunction in their platelets, and to study the mechanism behind the effect of the RGS2 mutation on platelet function and morphology. METHODS: Gs signaling was studied ex vivo in platelets and in vitro in transfected cells. Translation initiation was evaluated in vitro, and the interaction of wild-type and G23D RGS2 with AC was unraveled via immunoprecipitation. Platelet granule content was analyzed with proteomics. RESULTS: The mutation leads to reduced cAMP production after stimulation of Gs-coupled receptors. The largest RGS2 isoforms, with strong AC inhibitor activity, are enriched when the mutation is present, as compared with wild-type RGS2. Moreover, the mutation results in a stronger interaction of RGS2 with AC. G23D RGS2 carriers have enlarged, round platelets with abnormal alpha-granules. Proteomics of the platelet releasate revealed altered expression of some proteins involved in actin assembly, and carriers seemed to have a reduced platelet shape change. CONCLUSIONS: We present the first platelet Gs signaling defect caused by a heterozygous RGS2 variant that results in a unique mutational mechanism, such as the differential use of translation initiation sites resulting in different functional RGS2 isoforms.


Subject(s)
Blood Platelets/metabolism , GTP-Binding Proteins/metabolism , Mutation, Missense , RGS Proteins/physiology , Adenylyl Cyclase Inhibitors , Blood Platelets/pathology , Blood Platelets/physiology , Cell Shape/genetics , Heterozygote , Humans , Protein Biosynthesis , Protein Isoforms , RGS Proteins/genetics , Signal Transduction
4.
Heredity (Edinb) ; 101(2): 136-44, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18478027

ABSTRACT

Plant biodiversity must be safeguarded because it constitutes a resource of genes that may be used, for instance, in breeding programs. Lentil (Lens culinaris Medik.) is one of the most ancient crops of the Mediterranean region. Extensive differentiation of L. culinaris over millennia has resulted in a myriad of different landraces. However, in more recent times many landraces have disappeared consequent to environmental and socioeconomic changes. To promote the survival of endangered lentil landraces, we have investigated the genetic relationship between two ancient landrace cultivated in Capracotta and Conca Casale (Molise, south-central Italy) and widely spread commercial varieties using an integrated approach consisting of studies at morphological, DNA and protein level. Seeds of these two landraces were collected from local farmers and conserved in the Molise germoplasm bank. The two local landraces were well differentiated from each other, and the Conca Casale landrace was separated from the commercial varieties at morphological, protein and DNA level. The Capracotta landrace, was well separated from the commercial varieties, except Castelluccio di Norcia, at DNA level showing a more complex and heterogeneous segregation at morphological and biochemical level. The correlation between morphological, DNA and protein data, illustrates that proteomics is a powerful tool with which to complement the analysis of biodiversity in ecotypes of a single plant species and to identify physiological and/or environmental markers.


Subject(s)
Evolution, Molecular , Lens Plant/genetics , Lens Plant/metabolism , Proteomics/methods , DNA, Plant/genetics , Electrophoresis, Gel, Two-Dimensional , Italy , Lens Plant/chemistry , Lens Plant/classification , Plant Proteins/genetics , Plant Proteins/metabolism , Seeds/chemistry , Seeds/genetics , Seeds/metabolism , Sequence Analysis, DNA
5.
Clin Diagn Lab Immunol ; 4(2): 117-21, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9067642

ABSTRACT

Recent studies have identified several epitopes in the N-terminal portion of the nucleocapsid protein which are predominantly recognized by sera of patients infected with hepatitis C virus (HCV). The characterization of the sequences recognized by theses antibodies and the evaluation of their reactivities have been performed mainly with synthetic peptides. However, synthetic peptides are notoriously unreliable as antigens when the immune response is directed against conformational epitopes. In order to improve the detection of antibody responses in HCV-infected patients, we have evaluated the reactivities of three immunodominant regions of the HCV core protein (residues 1 to 20, 21 to 40, and 32 to 46) displayed in a conformation-specific manner on the surface of the Flock House virus (FHV) capsid protein. The results obtained with these proteins in the analysis of 94 serum samples positive by anti-HCV enzyme-linked immunosorbent assay where then compared with those obtained with the corresponding synthetic peptides. The sequence most reactive both with the peptide and with the FHV protein was the region from residues 1 to 20, confirming the low conformational requirements for the display of these residues. On the other hand, the already reported conformational nature of residues 32 to 46 is in keeping with its observed high reactivity when displayed by the FHV recombinant protein and with the low reactivity displayed by its corresponding synthetic peptide. Finally, the high reactivity observed for the chimeric protein displaying the region from residues 21 to 40, as opposed to the results obtained with the synthetic peptide, also suggests that this sequence contains one or more conformational epitopes whose structures cannot be mimicked correctly with synthetic peptides.


Subject(s)
Antigens, Viral/chemistry , Hepacivirus/immunology , Viral Core Proteins/immunology , Amino Acid Sequence , Antigen Presentation , Antigens, Viral/genetics , Enzyme-Linked Immunosorbent Assay , Hepacivirus/genetics , Hepatitis C/diagnosis , Hepatitis C/immunology , Hepatitis C/virology , Hepatitis C Antibodies/blood , Humans , Immunodominant Epitopes/chemistry , Immunodominant Epitopes/genetics , Models, Molecular , Molecular Sequence Data , Peptides/chemical synthesis , Peptides/chemistry , Peptides/immunology , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Viral Core Proteins/chemistry , Viral Core Proteins/genetics
6.
J Clin Microbiol ; 34(10): 2440-3, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8880496

ABSTRACT

The 16S-23S intergenic spacer region in 218 strains of Salmonella isolated from four Italian hospitals during the period from 1977 to 1994 was analyzed by PCR ribotyping. This molecular typing technique allowed for the identification of seven different and specific electrophoretic profiles for the seven serovars S: enteritidis, S. london, S. anatum, S. panama, S. heidelberg, S. agona, and S. goldcoast. Otherwise, the spacer region appears to be polymorphic in S. typhimurium S. infantis, and S. derby since we could identify eight, six, and four different ribotypes, respectively.


Subject(s)
RNA, Bacterial/analysis , RNA, Ribosomal/analysis , Salmonella/classification , Humans , Polymerase Chain Reaction , RNA, Bacterial/genetics , RNA, Ribosomal/genetics , Salmonella/genetics , Salmonella/isolation & purification , Serotyping
9.
G Ital Cardiol ; 9(9): 1028-9, 1979.
Article in Italian | MEDLINE | ID: mdl-520732

ABSTRACT

A long QT syndrome is described, followed by "torsade de pointe" that is ascribed to an hypopotassemia in a patient submitted to administration of prenylamine, vincamine, digitalis and furosemide. The efficacy of verapamil i.v. is related.


Subject(s)
Arrhythmias, Cardiac/etiology , Electrocardiography , Hypokalemia/complications , Verapamil/therapeutic use , Aged , Arrhythmias, Cardiac/drug therapy , Digitalis Glycosides/adverse effects , Female , Furosemide/adverse effects , Humans , Hypokalemia/chemically induced , Prenylamine/adverse effects , Tachycardia/etiology , Vincamine/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL